Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterNo recent work listed

Stephan Herzig

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3950-3652; OpenAlex author ID A5073008608. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Deletion of pancreas-specific miR-216a reduces beta-cell mass and inhibits pancreatic cancer progression in mice. Co-author DOI 10.1016/j.xcrm.2021.100434↗
  2. Transcriptional co-factor Transducin beta-like (TBL) 1 acts as a checkpoint in pancreatic cancer malignancy. Last author DOI 10.15252/emmm.201404837↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marina Lesina · 1 shared paper, 2021 · strength 0.10
  2. Süheda Erener · 1 shared paper, 2021 · strength 0.10
  3. Janel L. Kopp · 1 shared paper, 2021 · strength 0.10
  4. Timothy J. Kieffer · 1 shared paper, 2021 · strength 0.10
  5. Hana Algül · 1 shared paper, 2021 · strength 0.10
  6. Christian Stoy · 1 shared paper, 2015 · strength 0.04
  7. Andrea S. Bauer · 1 shared paper, 2015 · strength 0.04
  8. Thomas G. Hofmann · 1 shared paper, 2015 · strength 0.04
  9. Matthias M. Gaida · 1 shared paper, 2015 · strength 0.04
  10. Oliver Strobel · 1 shared paper, 2015 · strength 0.04
  11. Jörg D. Hoheisel · 1 shared paper, 2015 · strength 0.04
  12. Jens Werner · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.